Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen's Hawaii Biotech, Inc.
Avantogen Ltd welcomes Professor Ian Frazer to the Scientific Advisory Board of Hawaii Biotech Inc. (HBI), where Avantogen owns a significant portion of the total equity. Prof Frazer is an immunologist and the 2006 Australian of the Year. HBI is a privately held vaccine development company located in Honolulu, Hawaii.
Dr William Ardrey, CEO of Avantogen commented, "The addition of Prof Ian Frazer to Hawaii Biotech is a very positive development for Avantogen's shareholders. His appointment is seen as a validation of the technology platform as well as of the vaccines that are currently in clinical development at HBI. Previously, shareholders have seen progress with the US FDA and the West Nile Virus program. The Dengue program in conjunction with the Paediatric Dengue Vaccines Initiative (PDVI), funded by the Bill & Melinda Gates Foundation and Rockefeller Foundation, is also running according to schedule. We hope to deliver progress reports on these programs in the coming weeks."
Other news from the department people
